TickerFactsScreenerDevelopers

Tevogen Bio Holdings Inc. (TVGN) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2022: -$215.4K2023: -$8.17M2024: -$12.00M2025: -$12.33M-$12.33M
2022Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$12.33M-2.7%
2024-$12.00M-46.8%
2023-$8.17M-3693.6%
2022-$215.4K—